Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.52
-0.17 (-2.15%)
Sep 18, 2024, 4:00 PM EDT - Market closed

Profound Medical Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Profound Medical stock have an average target of 11.4, with a low estimate of 10.8 and a high estimate of 12. The average target predicts an increase of 51.60% from the current stock price of 7.52.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10.8 $11.4 $12 $12
Change +43.62% +51.60% +59.57% +59.57%
* Price targets were last updated on Jul 16, 2024.

Analyst Ratings

The average analyst rating for PROF stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '24May '24Jun '24Jul '24Aug '24Sep '24
Strong Buy 111222
Buy 222110
Hold 222000
Sell 000000
Strong Sell 000000
Total 555332

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Stifel
Stifel
Strong Buy
Upgrades
$9$12
Strong Buy Upgrades $9$12 +59.57% Jul 16, 2024
Alliance Global Partners
Alliance Global Partners
Strong Buy
Maintains
$13$11
Strong Buy Maintains $13$11 +43.62% Mar 11, 2024
Stifel
Stifel
Hold
Maintains
$11$9
Hold Maintains $11$9 +19.68% Mar 8, 2024
Alliance Global Partners
Alliance Global Partners
Strong Buy
Maintains
$14$13
Strong Buy Maintains $14$13 +69.55% Jan 4, 2024
Stifel
Stifel
Hold
Initiates
$11
Hold Initiates $11 +46.28% Nov 28, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
11.29M
from 7.20M
Increased by 56.87%
Revenue Next Year
29.58M
from 11.29M
Increased by 161.94%
EPS This Year
-1.14
from -1.35
EPS Next Year
-0.92
from -1.14
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
4.17M7.30M6.87M6.68M7.20M11.29M29.58M49.96M
Revenue Growth
60.40%74.99%-5.90%-2.79%7.75%56.87%161.94%68.90%
EPS
-1.37-1.25-1.50-1.38-1.35-1.14-0.92-0.49
EPS Growth
--------
Forward PE
--------
No. Analysts -----777
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 12.0M 49.8M 87.5M
Avg 11.3M 29.6M 50.0M
Low 10.7M 16.5M 32.2M

Revenue Growth

Revenue Growth 20242025202620272028
High
66.3%
340.7%
195.7%
Avg
56.9%
161.9%
68.9%
Low
48.5%
45.8%
9.0%

EPS Forecast

EPS 2024202520262027
High -1.03 -0.75 0.22
Avg -1.14 -0.92 -0.49
Low -1.17 -1.25 -1.24

EPS Growth

EPS Growth 2024202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.